Profile

MSN, MGH Institute of Health Professions




A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCX168 (AVACOPAN) IN PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITI
02/28/2017 - 02/27/2020 (Co-PI)
PI: Paul A. Monach, MD, PhD
ChemoCentryx, Inc.

A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF MEPOLIZUMAB IN THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS IN SUBJECTS RECEIVING STAND
09/24/2014 - 12/31/2018 (Co-PI)
PI: Paul A. Monach, MD, PhD
GlaxoSmithKline, Inc.




Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Mohammad AJ, Hot A, Arndt F, Moosig F, Guerry MJ, Amudala N, Smith R, Sivasothy P, Guillevin L, Merkel PA, Jayne DR. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Ann Rheum Dis. 2016 Feb; 75(2):396-401. PMID: 25467294; DOI: 10.1136/annrheumdis-2014-206095;.
     
  2. Grayson PC, Amudala NA, McAlear CA, Leduc RL, Shereff D, Richesson R, Fraenkel L, Merkel PA. Causal attributions about disease onset and relapse in patients with systemic vasculitis. J Rheumatol. 2014 May; 41(5):923-30. PMID: 24634202; PMCID: PMC4008683; DOI: 10.3899/jrheum.131096;.
     
  3. Grayson PC, Amudala NA, Mcalear CA, Leduc RL, Shereff D, Richesson R, Fraenkel L, Merkel PA. Illness perceptions and fatigue in systemic vasculitis. Arthritis Care Res (Hoboken). 2013 Nov; 65(11):1835-43. PMID: 23861259; PMCID: PMC3962511.
     
  4. Long-Middleton ER, Burke PJ, Cahill Lawrence CA, Blanchard LB, Amudala NH, Rankin SH. Understanding motivations for abstinence among adolescent young women: insights into effective sexual risk reduction strategies. J Pediatr Health Care. 2013 Sep-Oct; 27(5):342-50. PMID: 22525893; PMCID: PMC3434311; DOI: 10.1016/j.pedhc.2012.02.010;.
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.


Contact for Mentoring: